Case Report

Use of Cetirizine in a 23-Month-Old Male Causes Insomnia

Authors: Melissa C. Jones, PharmD, BCPS, Curtis E. Jones, II, PhD, RPh

Abstract

Allergic rhinitis affects approximately 40% of children and generally presents in children from 10-19 years of age; however, the condition has been seen in children as young as 6 months. Antihistamines are commonly prescribed in infants and children for the relief of allergic symptoms. A 23-month-old male with a history of chronic otitis media was prescribed cetirizine 2.5 mg daily at bedtime for maintenance of his chronic rhinitis symptoms. Several days into therapy, the child began experiencing frequent and progressive nighttime periods of awakening. Once treatment was discontinued, the child resumed his normal sleeping patterns.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Berger WE. Pediatric allergic rhinitis: antihistamine selection. Clin Pediatr (Phila) 2005;44:655–664.
2. Seth D, Secord E, Kamat D. Allergic rhinitis. Clin Pediatr (Phila) 2007;46:401–407.
 
3. Fireman P. Therapeutic approaches to allergic rhinitis: treating the child. J Allergy Clin Immunol 2000;105(6 pt 2):S616–S621.
 
4. Simons FE. Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child. J Allergy Clin Immunol 1999;104(2 pt 1):433–440.
 
5. Simons FE, Silas P, Portnoy JM, et al. Safety of cetirizine in infants 6 to 11 months of age: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 2003;111:1244–1248.